Trials / Completed
CompletedNCT05000541
Observation of the Effects of Guideline-driven Lifestyle Interventions, Including Use of a Red-yeast Based Nutraceutical
Observation of the Effects of Guideline-driven Lifestyle Interventions, Including Use of a Red-yeast Based Nutraceutical , in Subjects With Hypercholesterolemia at Low-moderate Cardiovascular Risk Not Requiring a Drug Therapy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 259 (actual)
- Sponsor
- Mylan Inc. · Industry
- Sex
- All
- Age
- 25 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the present multinational, multicentre, prospective, scientific study is to confirm that prescription of a low-dose red yeast-based nutraceutical.
Detailed description
The objective of the present multinational, multicentre, prospective, scientific study is to confirm that prescription of a low-dose red yeast-based nutraceutical significantly increases the LDL-C lowering effect of guideline-driven lifestyle interventions in subjects with hypercholesterolemia at low-moderate cardiovascular risk not requiring a drug therapy.
Conditions
Timeline
- Start date
- 2020-12-08
- Primary completion
- 2023-10-31
- Completion
- 2023-10-31
- First posted
- 2021-08-11
- Last updated
- 2023-11-07
Locations
7 sites across 2 countries: Austria, Germany
Source: ClinicalTrials.gov record NCT05000541. Inclusion in this directory is not an endorsement.